From small beginnings: to build an anti-eugenic future
By Benedict Ipgrave, Miroslava Chavez-Garcia, Marcy Darnovsky, Subhadra Das, Charlene Galarneau, Rosemarie Garland-Thomson, Nora Ellen Groce, Tony Platt, Milton Reynolds, Marius Turda, Robert A Wilson,
The Lancet
| 05. 21. 2022
September, 1921 was unusually hot and New York was sweltering. For the many immigrants who crowded the city's tenements and pavements, one of the few places for relief from the incessant heat was the American Museum of Natural History. That summer the museum presented a new exhibition with rows of human skulls, snapshots of patients in psychiatric institutions, and the preserved brain of a serial killer. It was all terribly macabre. The immigrants among the museum's visitors who read the leaflet distributed at the entrance soon discovered that this exhibition was all about them. It included charts showing how migration eroded societies, statistics from IQ tests of arrivals at Ellis Island, and posters spouting anti-migrant rhetoric. All conveyed the same message: “your tired, your poor, your huddled masses yearning to breathe free” were not welcome here.
Meanwhile, just upstairs the Second International Eugenics Congress was in full swing. The ramifications of this conference would be felt across the world. Leading eugenicists at the conference argued that the science of eugenics would enable the betterment of the human “race” by selective...
Related Articles
By Liyan Qi and Jonathan Cheng, The Wall Street Journal | 03.26.2025
photo via Wikimedia Commons licensed under CC by 3.0
Chinese scientist He Jiankui set off global outrage and landed in prison after he skirted ethical guidelines and claimed he had produced genetically modified babies designed to resist HIV infection.
Now, the self-styled ...
By Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi, MIT Technology Review | 03.25.2025
Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation...
By Anna Louie Sussman, The New York Times | 03.25.2025
On June 24, 2022, the same day the Supreme Court issued its decision in Dobbs v. Jackson Women’s Health Organization, I received a call from the fertility clinic where I’d been undergoing in vitro fertilization, informing me that seven of...
By Michael Gibney, PharmaVoice | 03.20.2025
The death this week of a teenager receiving Sarepta Therapeutics’ gene therapy Elevidys for Duchenne muscular dystrophy is a tragic reminder of the stakes involved in cutting-edge biotech innovation.
While gene therapies like Sarepta’s offer an opportunity to treat and...